EuroPCR 2019: JenaValve™ TAVI System - Prof Stephan Baldus
EuroPCR 2019: FORWARD PRO Study - Prof Eberhard Grube
A new evolution in treatment: TAVR for aortic regurgitation with the Jenavalve Trilogy System
Challenges with re-accessing the coronaries after TAVI - EuroPCR 2019
JenaValve
Transcatheter options for AR open up TAVI to a new patient population
TAVI in Aortic Regurgitation
Valve-in-valve: the journey starts with the first prosthesis - EuroPCR 2022
Double jeopardy: coronary disease in patients undergoing TAVI - EuroPCR 2022
CVI 2019_Friday 7/19_ The Boundaries of Structural Heart Therapy I _Scott Lilly, MD, PhD
TAVI in Low Risk Patients - Prof Ravinay Bhindi
TAVI industry update
Treatment Strategies - EuroPCR 2013 - Sara Taheri interviews Helmut Straubinger, CEO, JenaValve
Introducing ACURATE neo™ TF TAVI - EuroPCR Tools & Techniques
EuroPCR 2019: GLOBAL LEADERS Study - Prof Patrick W. Serruys
The uncompromised hemodynamics of the ALLEGRA™ transfemoral TAVI system - PCR London Valves 2021
EuroPCR 2019: OCT-based FFR - Prof Shengxian Tu
Impact of procedural outcomes on future TAVI treatment options - Webinar
Gimv's investment in Jenavalve, company developing transcatheter aortic valves
EuroPCR 2021 - Focus on TAVI valve-in-valve
